根除幽门螺杆菌治疗失败的4大原因!

2018-04-15 王伯军 王伯军大夫谈消化

幽门螺杆菌(Hp)是慢性胃炎、消化性溃疡、胃癌等最常见的原因之一,2015年《京都共识》提出Hp相关的慢性胃炎是传染病,每个Hp感染的患者均应根除Hp。

即使按照国内指南治疗,Hp根除率还是在50%~90% ,为什么?

幽门螺杆菌(Hp)是慢性胃炎、消化性溃疡、胃癌等最常见的原因之一,2015年《京都共识》提出Hp相关的慢性胃炎是传染病,每个Hp感染的患者均应根除Hp。

但即使按照国内指南,正规Hp四联疗法(双倍剂量质子泵抑制剂+两个抗生素+铋剂),治疗14天,抗生素也按指南推荐(阿莫西林、克拉霉素、呋喃唑酮、左氧氟沙星、四环素、甲硝唑)选用,Hp根除率也还在50%~90% ,相差悬殊!

为何Hp根除会失败,这是什么原因?影响Hp根除治疗的因素有哪些?

一、细菌因素

1. Hp耐药是根除失败的最主要原因

随着抗生素的广泛使用,Hp通过基因突变,对多种抗菌药物产生耐药,尤其是对甲硝唑和克拉霉素耐药的广泛流行,是导致Hp根除失败的重要原因。

目前Hp对甲硝唑的耐药率高达90%、克拉霉素36%、左氧氟沙星32%左右,对呋喃唑酮的耐药率各地区差异较大,在6%到50%之间,对阿莫西林、四环素的耐药率总体上还是比较低。随着抗生素的广泛使用,Hp对抗生素的耐药率逐步上升。

各地由于抗生素使用习惯的差异Hp耐药情况差别很大。

然而,即使采用对Hp均敏感的抗菌药物,也仍有部分患者治疗失败。在Hp根除失败的患者中约有50%不能用Hp耐药解释,而是与其他因素有关。

2. Hp毒力因子

Hp毒力因子主要是:空泡细胞毒素(VacA)和细胞毒素相关蛋白(CagA)。这两种毒素在Hp致病中起重要作用,与临床疾病的严重程度密切相关,其对根除治疗也有一定影响。CagA阴性菌株复制速度低于CagA阳性菌株,从而导致其对抗菌药物敏感性降低,是导致治疗失败的原因之一。

3. Hp在胃内定植部位

Hp在胃内呈局灶性分布,不同部位的Hp对抗生素的敏感性有差异。

动物实验显示,定植于胃窦胃体交界区域的Hp对抗生素敏感性差,可能会逃脱抗菌药物的作用,导致治疗失败。

研究还发现,在单独使用抑酸剂时,定植在胃窦的Hp数量明显降低,而胃体Hp数量则明显升高。这会降低其后根除Hp的疗效,故在Hp根除治疗前不宜使用质子泵抑制剂。

4. Hp负荷量

胃内细菌负荷量过高,易导致Hp根除失败,加用铋剂可提高疗效。

Hp呼气试验、胃黏膜组织切片染色、快速尿素酶试验,可半定量反映细菌负荷量的高低。后两者要经胃镜活检取材,可显示Hp+、++、+++,“+”号越多表示细菌越多。13C-呼气试验DOB值高于正常值的10倍时,提示细菌负荷量过高。

二、宿主因素

1. 患者依从性差

采用共识标准方案治疗时,除细菌对抗生素耐药影响患者的疗效外,患者依从性差是治疗失败的一个常见原因。

依从性差的患者,常常表现为:随便停药、间断治疗、没按时完成疗程、随意减少剂量、没按规定方法服药等等。

一项临床研究显示,有10%依从性差的患者其服药量低于总体应服药量的85%,从而导致其根除率降低。

患者依从性差不但易导致治疗失败,而且由于不规范服药,易导致Hp耐药,使以后的治疗更加困难。

2. 胃内pH值

多数抗生素如阿莫西林、克拉霉素等,其抗菌活性与胃内酸度相关,在无酸环境下才能发挥最大抗菌作用,因此在根除Hp治疗方案中需加入双倍剂量的质子泵抑制剂以提高胃内pH值,从而提高抗生素对Hp的抗菌活性。

3. 宿主基因型

药物主要在肝内代谢,质子泵抑制剂的代谢主要通过肝内CYP2C19途径,根据其代谢的强弱,分强代谢型者、弱代谢者。前者服药后很快在体内被清除,血中药物浓度明显低于后者,即抑制胃酸的效果较差。因此,CYP2C19强代谢型也是导致Hp根除治疗失败的重要原因之一。

质子泵抑制剂如奥美拉唑、潘托拉唑、兰索拉唑,更依赖CYP2C19代谢途径,强代谢型者使用这些质子泵抑制剂效果就比较差。雷贝拉唑、埃索美拉唑较少依赖CYP2C19代谢途径,对强代谢型、弱代谢者的疗效差别不大。

目前临床上无法预知那一个是强代谢型者还是弱代谢者。当使用奥美拉唑、潘托拉唑、兰索拉唑效果不好时,改用雷贝拉唑、埃索美拉唑可提高疗效。

4. 宿主免疫状态

研究表明,Hp根除失败的患者血清白细胞介素(IL)-4水平比成功根除Hp者明显降低。因此,如检测发现患者血清IL4水平降低,有可能预示患者Hp根除治疗更易失败。

予长期感染Hp的小鼠口服治疗性Hp疫苗,通过Th2细胞活化介导的胃肠道黏膜免疫反应,即提高局部的免疫功能,可将Hp成功根除。

5. 女性Hp治疗失败率高于男性

美国一项纳入3624例患者的meta分析发现,女性患者对甲硝唑和克拉霉素的耐药率明显高于男性,从而导致治疗失败。其他研究,台湾女性患者甲硝唑原发耐药高于男性;北京女性患者甲硝唑、左氧氟沙星耐药率高于男性;越南女性患者左氧氟沙星耐药率高于男性等。

6. 老年患者Hp根除率通常高于年轻患者

日本一项研究显示,在采用兰索拉唑联合阿莫西林和克拉霉素三联疗法一线治疗时,年龄>50岁者根除成功率高于年龄<50岁者。

这是老年患者用药依从性更好;萎缩性胃炎发生率高,致胃酸分泌减少。

7. 吸烟会降低Hp根除率

研究提示,吸烟的十二指肠溃疡患者Hp根除率明显低于不吸烟者。

吸烟可降低胃黏膜血流量,减少胃黏液分泌,从而减少到达胃黏膜的抗菌药物量;吸烟可刺激胃酸分泌,降低酸敏感抗生素如阿莫西林、克拉霉素的疗效;吸烟可能会降低患者的治疗依从性。

8. 口腔Hp问题

胃病患者的牙菌斑中能成功分离培养出Hp,口腔可能是Hp的另一个居留地,是Hp根除失败或复发的重要原因,并可能是Hp传播的重要途径。

口腔牙菌斑中微生物具有独特的“生物膜”结构,常规Hp根除治疗对口腔Hp无效。

对Hp根除反复失败者采用雷贝拉唑+铋剂+阿莫西林+呋喃唑酮治疗10天,同时进行口腔洁治,其Hp根除率85.9%高于单用四联疗法的患者75.0% 。这提示多次Hp根除失败者在治疗的同时进行口腔洁治可提高Hp根除率。

三、糖尿病是Hp根除失败的危险因素

—项纳入了8项研究共966例患者的meta分析显示,糖尿病是Hp根除失败的危险因素。与非糖尿病患者相比,糖尿病患者Hp根除失败的危险比为2.19,提示糖尿病患者在治疗Hp感染时需延长疗程并有待开发出新的治疗方案。

可能原因有:糖尿病患者易感染,常频繁、大量使用抗生素,使其对抗生素的耐药率提高;糖尿病微血管病变引起抗生素的吸收减少;根除后再感染较多。

四、环境因素导致Hp再感染

Hp治疗后,要确定Hp是否被根除,需在Hp根除治疗结束至少4周后再复查,通常采用Hp呼气试验来检测。

因为4周之前检测,Hp如没被杀灭只被抑制,Hp检测仍可显示阴性,但4周以后Hp可重新繁殖,此时检测又会阳性。

但在患者等待复查期间就有可能再次被感染。

流行病学调查提示,Hp感染主要与生活环境和生活习惯有关,显示出明显的家庭聚集性。Hp的重要传播途径是人→人传播,而经济状况和卫生条件差、文化程度低、居住拥挤以及非自来水水源等因素均是Hp感染或再感染的高危因素。

因此,目前强调家庭成员中一人感染Hp,全部成员均需检测Hp,并进行Hp根除治疗,以防家庭成员之间相互传染。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-19 风铃830
  3. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-09-03 kcb069
  4. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-21 152200a974m

    口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-19 张新亮1853311252142e2fm

    好文献.学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-18 大爰

    学习了谢谢分享!!

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-16 瑞德

    受益匪浅!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-16 121832a9m88暂无昵称

    学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-15 yfjms

    学习

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1717276, encodeId=025a1e17276e0, content=<a href='/topic/show?id=e3436460313' target=_blank style='color:#2F92EE;'>#治疗失败#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64603, encryptionId=e3436460313, topicName=治疗失败)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1c332383811, createdName=ligang4450, createdTime=Sat Sep 22 00:27:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683667, encodeId=8032168366efd, content=<a href='/topic/show?id=c2fc6228167' target=_blank style='color:#2F92EE;'>#根除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62281, encryptionId=c2fc6228167, topicName=根除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07d627990740, createdName=风铃830, createdTime=Thu Apr 19 00:27:00 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1811750, encodeId=eebf1811e507f, content=<a href='/topic/show?id=751f8889423' target=_blank style='color:#2F92EE;'>#螺杆菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88894, encryptionId=751f8889423, topicName=螺杆菌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Mon Sep 03 21:27:00 CST 2018, time=2018-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307750, encodeId=29ae30e75030, content=口服Hp疫苗就是个骗局 IL-4 Th2免疫 和抗菌应答有何关系?误导读者, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c572149708, createdName=152200a974m, createdTime=Sat Apr 21 01:12:21 CST 2018, time=2018-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307170, encodeId=107d30e1709e, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Thu Apr 19 06:56:33 CST 2018, time=2018-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306944, encodeId=01cf306944aa, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Wed Apr 18 11:45:01 CST 2018, time=2018-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306411, encodeId=9f973064111f, content=受益匪浅!, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63822007469, createdName=瑞德, createdTime=Mon Apr 16 21:55:04 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=306184, encodeId=5f85306184c7, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f22260741, createdName=121832a9m88暂无昵称, createdTime=Mon Apr 16 05:54:02 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305989, encodeId=088d305989e0, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Sun Apr 15 10:53:41 CST 2018, time=2018-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=305959, encodeId=fd733059591a, content=学习了.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJBX1icpnQZGQQNghseQialD5fIdFYbCfib2KH6iavWiaGaHQcbNwcOK2BNwaWPZicW8KsJ32ia6a6iaSkwGQ/132, createdBy=1b902300955, createdName=weiwei412720_57191401, createdTime=Sun Apr 15 09:34:54 CST 2018, time=2018-04-15, status=1, ipAttribution=)]
    2018-04-15 weiwei412720_57191401

    学习了.继续关注

    0

相关资讯

Nature长文惹争议:用PGD根除遗传病?在中国繁荣是必然趋势

《自然》专访了北医三院乔杰院长、上海交通大学的遗传学家兼中国遗传学会遗传咨询分会主席贺林院士、北京解放军总医院聋病专家兼“中国聋病基因组计划”发起者王秋菊教授等业内专家,指出了中国生殖医学中心正在大力促进胚胎植入前遗传学诊断(PGD)的普及,目的是根除某些疾病的产生。近日,英国的罕见病研究机构Rare Disease Report 官网就对Nature的这一报道进行了点评。

Scient Rep:“根除”艾滋病毒的新方法

近年来,艾滋病的治疗方法与日俱进,但是谈到根治始终有一段很远的距离。日前,日本熊本大学的研究人员开发了一种新的化合物,是破坏艾滋病病毒的关键。化合物引入感染细胞时,从而围在宿主细胞周围的病毒释放,然后通过细胞凋亡的过程,细胞自然死亡。这种疗法是可以使艾滋病在不久的将来的完全恢复的希望。

幽门螺旋杆菌的根除策略

应该在什么情况下根除HP?如何选择最优的治疗方案同时在根除失败后如何应对?抗生素如何正确使用及体检发现幽门螺杆菌阳性如何处理?这些问题都是临床医生面对的难题!